TILT Holdings (TLLTF) Equity Average (2021 - 2025)
TILT Holdings (TLLTF) reported Equity Average of -$56.4 million for Q2 2025, down 261.7% on a YoY basis from $34.9 million in Q2 2024, and down 28.8% quarter-over-quarter from -$43.8 million in Q1 2025.
TILT Holdings (TLLTF) Equity Average (2021 - 2025) Analysis & Trends
TILT Holdings has reported Equity Average for 5 years, with the latest figure at -$56.4 million in Q2 2025.
- For the quarter ending Q2 2025, Equity Average fell 261.7% year-over-year to -$56.4 million; the trailing twelve-month figure through Jun 2025 stood at -$56.4 million (down 261.7% YoY), and the FY2024 full-year result was $12.6 million, down 86.3% from the prior year.
- Equity Average for Q2 2025 stood at -$56.4 million, down from -$43.8 million in the prior quarter.
- The five-year high for Equity Average was $242.8 million in Q3 2021, with the low at -$56.4 million in Q2 2025.
- Historically, Equity Average has averaged $102.8 million across 5 years, with a median of $97.2 million in 2023.
- Annual changes were most pronounced in 2022 — Equity Average declined 17.05% — and 2025, when it sank 261.7%.
- TILT Holdings' Equity Average stood at $235.0 million in 2021, then slumped by 32.92% to $157.7 million in 2022, then tumbled by 53.53% to $73.3 million in 2023, then plunged by 122.39% to -$16.4 million in 2024, then plunged by 243.89% to -$56.4 million in 2025.
- The last three Equity Average figures came in at -$56.4 million (Q2 2025), -$43.8 million (Q1 2025), and -$16.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.15 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 493.55 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn | -56.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -56.40 Mn |
| Mar 31, 2025 | -43.79 Mn |
| Dec 31, 2024 | -16.40 Mn |
| Sep 30, 2024 | 10.66 Mn |
| Jun 30, 2024 | 34.88 Mn |
| Mar 31, 2024 | 57.62 Mn |
| Dec 31, 2023 | 73.27 Mn |
| Sep 30, 2023 | 87.74 Mn |
| Jun 30, 2023 | 106.70 Mn |
| Mar 31, 2023 | 121.78 Mn |
| Dec 31, 2022 | 157.67 Mn |
| Sep 30, 2022 | 201.41 Mn |
| Jun 30, 2022 | 212.12 Mn |
| Mar 31, 2022 | 220.46 Mn |
| Dec 31, 2021 | 235.03 Mn |
| Sep 30, 2021 | 242.80 Mn |